Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves

Warren V. Kalina, Amelia R. Woolums, Laurel J Gershwin

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Respiratory syncytial virus (RSV) causes severe respiratory disease in calves and human infants. In response to outbreaks, formalin inactivated (FI)-RSV vaccines were developed and found to exacerbate disease following a live RSV infection. We have reproduced vaccination induced disease enhancement in calves and screened various antibody isotypes in bronchoalveolar lavage fluid (BALF) from two studies: one with disease enhancement and another where moderate protection resulted from FI-bovine RSV (BRSV) vaccination. Semi-protected vaccinated calves produced BRSV-specific BALF IgG1, but not IgA and IgG2 prior to infection; whereas, calves with enhanced disease failed to develop BRSV-specific IgG1 in BALF. Ultimately, the formulation and delivery of RSV vaccines influences protective antibody levels in respiratory secretions.

Original languageEnglish (US)
Pages (from-to)4625-4630
Number of pages6
JournalVaccine
Volume23
Issue number37
DOIs
StatePublished - Aug 31 2005

Fingerprint

Respiratory Syncytial Virus Vaccines
Bovine respiratory syncytial virus
Bronchoalveolar Lavage Fluid
formalin
Formaldehyde
calves
vaccines
viruses
antibodies
Antibodies
Immunoglobulin G
vaccination
Vaccination
cattle
Respiratory Syncytial Virus Infections
infection
Respiratory Syncytial Viruses
respiratory tract diseases
Immunoglobulin A
secretion

Keywords

  • BALF
  • BRSV
  • FI-BRSV

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves. / Kalina, Warren V.; Woolums, Amelia R.; Gershwin, Laurel J.

In: Vaccine, Vol. 23, No. 37, 31.08.2005, p. 4625-4630.

Research output: Contribution to journalArticle

@article{a35a879c39614ffaa8ba2c83e6ae8c64,
title = "Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves",
abstract = "Respiratory syncytial virus (RSV) causes severe respiratory disease in calves and human infants. In response to outbreaks, formalin inactivated (FI)-RSV vaccines were developed and found to exacerbate disease following a live RSV infection. We have reproduced vaccination induced disease enhancement in calves and screened various antibody isotypes in bronchoalveolar lavage fluid (BALF) from two studies: one with disease enhancement and another where moderate protection resulted from FI-bovine RSV (BRSV) vaccination. Semi-protected vaccinated calves produced BRSV-specific BALF IgG1, but not IgA and IgG2 prior to infection; whereas, calves with enhanced disease failed to develop BRSV-specific IgG1 in BALF. Ultimately, the formulation and delivery of RSV vaccines influences protective antibody levels in respiratory secretions.",
keywords = "BALF, BRSV, FI-BRSV",
author = "Kalina, {Warren V.} and Woolums, {Amelia R.} and Gershwin, {Laurel J}",
year = "2005",
month = "8",
day = "31",
doi = "10.1016/j.vaccine.2005.04.032",
language = "English (US)",
volume = "23",
pages = "4625--4630",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "37",

}

TY - JOUR

T1 - Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves

AU - Kalina, Warren V.

AU - Woolums, Amelia R.

AU - Gershwin, Laurel J

PY - 2005/8/31

Y1 - 2005/8/31

N2 - Respiratory syncytial virus (RSV) causes severe respiratory disease in calves and human infants. In response to outbreaks, formalin inactivated (FI)-RSV vaccines were developed and found to exacerbate disease following a live RSV infection. We have reproduced vaccination induced disease enhancement in calves and screened various antibody isotypes in bronchoalveolar lavage fluid (BALF) from two studies: one with disease enhancement and another where moderate protection resulted from FI-bovine RSV (BRSV) vaccination. Semi-protected vaccinated calves produced BRSV-specific BALF IgG1, but not IgA and IgG2 prior to infection; whereas, calves with enhanced disease failed to develop BRSV-specific IgG1 in BALF. Ultimately, the formulation and delivery of RSV vaccines influences protective antibody levels in respiratory secretions.

AB - Respiratory syncytial virus (RSV) causes severe respiratory disease in calves and human infants. In response to outbreaks, formalin inactivated (FI)-RSV vaccines were developed and found to exacerbate disease following a live RSV infection. We have reproduced vaccination induced disease enhancement in calves and screened various antibody isotypes in bronchoalveolar lavage fluid (BALF) from two studies: one with disease enhancement and another where moderate protection resulted from FI-bovine RSV (BRSV) vaccination. Semi-protected vaccinated calves produced BRSV-specific BALF IgG1, but not IgA and IgG2 prior to infection; whereas, calves with enhanced disease failed to develop BRSV-specific IgG1 in BALF. Ultimately, the formulation and delivery of RSV vaccines influences protective antibody levels in respiratory secretions.

KW - BALF

KW - BRSV

KW - FI-BRSV

UR - http://www.scopus.com/inward/record.url?scp=22744449046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22744449046&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2005.04.032

DO - 10.1016/j.vaccine.2005.04.032

M3 - Article

C2 - 15967545

AN - SCOPUS:22744449046

VL - 23

SP - 4625

EP - 4630

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 37

ER -